Agenda
The Program That Moves Medicine Forward
8:00 – 9:00 AM
Check In and Connect
Start the day by registering, picking up your badge, and enjoying coffee or tea as you meet fellow clinicians.
9:00 – 9:45 AM
Welcome to OWL’25!
9:45 – 10:30 AM
CPD: Peptides as Therapeutic Options
10:30 – 11:15 AM
CPD: The Endocannabinoid System — The Science Behind Medicinal Cannabis
11:15 – 11:30 AM
BREAK
11:30 – 12:15 PM
How Sleep, Neurodevelopment, and Hyperbaric Oxygen Therapy Unlock the Source Codes of Longevity
In this presentation, Dr. Reza Samvat examines the critical role of sleep, neurodevelopment, and hyperbaric oxygen therapy in promoting longevity. He will outline how restorative sleep regulates cognition, emotions, and physical repair; how neuroplasticity and balanced brain symmetry support optimal function; and how hyperbaric oxygen therapy enhances cellular repair, telomere integrity, circulation, and resilience. By integrating these interconnected systems, Dr. Samvat presents practical, evidence-informed strategies that activate the body’s “source codes” for longevity—the biological pathways that sustain vitality, performance, and healthy aging.
12:15 – 1:15 PM
LUNCH & EXHIBITOR VISIT
1:15 – 2:00 PM
CPD: Harnessing AI and Machine Learning to Transform Clinical Practice
Description: This session will explore the dynamic intersection of artificial intelligence (AI) and machine learning (ML) with modern clinical practice. Attendees will gain insights into how these technologies are reshaping diagnostics, treatment planning, and patient management. The talk will cover real-world case studies, practical integration strategies, and the challenges—including ethical and regulatory considerations—that come with implementing AI/ML in healthcare settings. Participants will leave with a deeper understanding of how to leverage data-driven tools to enhance clinical decision-making and improve patient outcomes.
Learning Outcomes:
Understand Language Model Fundamentals: Grasp the core concepts of artificial intelligence and machine learning and their relevance to clinical environments.
Identify Practical Applications: Recognize key applications of AI/ML in diagnostics, personalized treatment plans, and predictive analytics within healthcare.
Evaluate Benefits and Challenges: Analyze the benefits, limitations, and ethical considerations of integrating AI/ML into clinical practice.
Implement Integration Strategies: Learn actionable strategies for incorporating AI/ML tools into existing clinical workflows to drive innovation and improve patient care.
2:00 – 3:00 PM
Why Psychedelics? Their Journey with Human Wellbeing
3:00 – 3:15 PM
BREAK
3:15 – 4:00 PM
HBOT
4:00 – 4:45 PM
Reboot the Body from the Inside Out: Systemic Stem Cells, Autophagy, and Physiological Balance
4:45 – 5:30 PM
6 Pillars
8:00 – 8:30 AM
Morning Networking Coffee
8:15 – 9:00 AM
Evidence-base of Medicinal Cannabis in Anxiety
Description: In this presentation Prof Kylie O’Brien will discuss the scientific evidence of efficacy for medicinal cannabis in the treatment of anxiety, including reporting on results of Project Twenty21 Australia, a two year observational study conducted in Australia.
9:00 – 9:45 AM
Psilocybin & MDMA: How They’re Used for Therapy & the Role of the GP (CPD)
9:45 – 10:30 AM
IV Therapy and NAD+
10:30 – 10:45 AM
BREAK
10:45 – 11:30 AM
Practical Pain & Regenerative Cases
11:30 – 12:15 PM
Mitochondria–Microbiome–Calorie Reset
12:15 – 1:00 PM
The Ethics, Narratives, and Future of Psychedelic Medicine
Description: I will discuss my 15 years of experience initiating psychedelic research in Australia, my involvement in that research and my current work as an Authorised Psychiatric Prescriber of psychedelic medicines in Australia.
I will particularly focus on my research using psychedelics for non-therapeutic purposes - namely the development of well being using, in particular nature relatedness and positive aesthetics.
I will present my current therapeutic model based on the careful selection of subjects most likely to respond to a psychedelic experience, the importance of a beautiful and natural setting for the experience and for the development of a positive mind set, and the imaginative and meditative techniques I use to support this process.
1:00 – 2:00 PM
LUNCH
2:00 – 2:45 PM
Treatment Plans and Stacking Cannabinoids to Create Targeted Therapies
2:45 – 3:30 PM
PRP & Stem Cells in Musculoskeletal Context + Peptide Protocols
Description: This talk will delve into the framework of clinical governance that governs the safe and effective dispensation of peptide therapies in Australia. It will outline the regulatory landscape, quality assurance protocols, and best practice guidelines that clinicians and pharmacists must follow. Emphasis will be placed on ensuring patient safety, maintaining compliance with national standards, and navigating the complexities of peptide-based treatments. Real-world examples and case studies will illustrate how robust governance frameworks can facilitate the responsible use of peptide therapies in clinical settings.
Learning Outcomes:
Understand Regulatory Frameworks: Gain a clear understanding of the current regulations and standards governing peptide dispensation in Australia.
Learn Best Practice Guidelines: Identify best practices and quality assurance measures that ensure safe, effective, and ethical peptide use in clinical settings.
Apply Clinical Governance Principles: Develop the ability to implement clinical governance strategies that manage risk and enhance patient safety in the context of peptide therapies.
Evaluate Real-World Scenarios: Analyze case studies and practical examples to understand common challenges and effective solutions in peptide dispensation.
